Compounds > buthionine sulfoximine

Page last updated: 2024-08-22

buthionine sulfoximine and fenretinide

buthionine sulfoximine has been researched along with fenretinide in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (83.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J	1
Fujii, H; Goto, H; Ikuta, K; Takahashi, H; Yokota, S	1
Frgala, T; Kalous, O; Proffitt, RT; Reynolds, CP	1
Burchill, SA; Magwere, T; Myatt, SS	1
Bras, J; Caron, HN; Cuperus, R; Leen, R; Tytgat, GA; van Kuilenburg, AB	1

Other Studies

6 other study(ies) available for buthionine sulfoximine and fenretinide

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology, 2009, Volume: 5, Issue:10 Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection	2009
N-(4-Hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species. International journal of hematology, 2003, Volume: 78, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Buthionine Sulfoximine; Cell Line, Tumor; Dose-Response Relationship, Drug; Fenretinide; Glutathione; Humans; Leukemia; Oxidative Stress; Reactive Oxygen Species	2003
A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations. Molecular cancer therapeutics, 2007, Volume: 6, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Cell Proliferation; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Eosine Yellowish-(YS); Fenretinide; Fluorescent Dyes; Humans; Leukemia; Melphalan; Microscopy, Fluorescence; Neuroblastoma; Protein Kinase C; Sphingosine; Tumor Cells, Cultured; Tumor Stem Cell Assay	2007
Manipulation of oxidative stress to induce cell death in Ewing's sarcoma family of tumours. European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:15 Topics: Antineoplastic Agents; Antioxidants; Bone Neoplasms; Buthionine Sulfoximine; Cell Death; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fenretinide; Glutathione; Humans; Oxidation-Reduction; Oxidative Stress; Oxidoreductases; Reactive Oxygen Species; Sarcoma, Ewing; Tumor Cells, Cultured	2008
Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids. Free radical biology & medicine, 2011, Sep-15, Volume: 51, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Buthionine Sulfoximine; Cell Line; Drug Synergism; Fenretinide; Glutathione; Growth Inhibitors; Humans; Neuroblastoma; Reactive Oxygen Species; Spheroids, Cellular	2011